Pharmaceuticals Market Research Reports

Global Chronic Disorder Drugs Market By Therapy (Small-Molecule Drugs, Biologics & Targeted Therapies, Supportive/Adjunctive Therapies), By Disease (Cardiovascular, Diabetes, Respiratory, Cancer & Other Chronic Conditions), By Route of Administration (Oral, Parenteral, Inhaled & Other), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025–2035

Report Overview In 2025, the Global Chronic Disorder Drugs Market was valued at US$ 7.1 Billion, and between 2026 and 2035, this market is estimated to register a CAGR of 14.1%, reac...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 312
- US $3,999 Onwards
- Formats:
Global Vutrisiran Market By Product Type (Antisense Oligonucleotide, Nucleotide, Nucleic Acids, Nucleoside and Others), By Route of Administration (Oral, Subcutaneous and Injectable), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Vutrisiran Market size is expected to be worth around US$ 3.2 Billion by 2035 from US$ 0.9 billion in 2025, growing at a CAGR of 13.4% during the forecast peri...
- ★★★★★
  
  ★★★★★
  
  (142)
- Feb 2026
- Pages: 322
- US $3,999 Onwards
- Formats:
Global Pericarditis Drugs Market By Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Colchicine, Corticosteroids, Others) By Route of Administration (Oral, Injectable, Others) By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Pericarditis Drugs Market size is expected to be worth around US$ 7.3 Billion by 2035 from US$ 4.2 Billion in 2025, growing at a CAGR of 5.7% during the foreca...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 326
- US $3,999 Onwards
- Formats:
Global DTP Vaccines Market By Product Type(DTaP (Diphtheria, Tetanus, acellular Pertussis), DTwP (Diphtheria, Tetanus, whole-cell Pertussis), Tdap (Tetanus, Diphtheria, acellular Pertussis), Others (DT, Td, etc.)) By Age Group (Pediatric, Adolescent, Adult) By End User( Hospitals, Clinics and Vaccination Centers, Community Health Centers, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global DTP Vaccines Market size is expected to be worth around US$ 35.3 Billion by 2035 from US$ 8.5 Billion in 2025, growing at a CAGR of 15.3% during the forecast p...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 243
- US $3,999 Onwards
- Formats:
Global Gaucher Disease Drugs Market By Drug Type (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Chaperone Therapy, Others) By Route of Administration (Intravenous, Oral, Others) By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Gaucher Disease Drugs Market size is expected to be worth around US$ 2.2 Billion by 2035 from US$ 1.7 Billion in 2025, growing at a CAGR of 2.7% during the for...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 203
- US $3,999 Onwards
- Formats:
Global Addisons Disease Drugs Market By Drug Type (Corticosteroids (Glucocorticoids), Mineralocorticoids, Others) By Corticosteroid Type (Hydrocortisone, Prednisolone, Dexamethasone, Others) By Route of Administration (Oral, Injectable, Others) By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Addisons Disease Drugs Market size is expected to be worth around US$ 1,492.4 Million by 2035 from US$ 671.0 Million in 2025, growing at a CAGR of 8.4% during ...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 221
- US $3,999 Onwards
- Formats:

« Previous 1 2 3 4 … 69 Next »